Trends in Prices of Drugs Used to Treat Metastatic Non–Small Cell Lung Cancer in the US From 2015 to 2020

IMPORTANCE: Oncology drug prices are a determinant of health disparities in the US and worldwide. Several new therapeutic agents for non–small cell lung cancer (NSCLC) have become available on the US market over the past decade. Although increased competition typically produces lower prices, competi...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Aakash, Scheckel, Caleb, Jensen, Chelsee J., Orme, Jacob, Williams, Colt, Shah, Nilay, Leventakos, Konstantinos, Adjei, Alex A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790662/
https://www.ncbi.nlm.nih.gov/pubmed/35076701
http://dx.doi.org/10.1001/jamanetworkopen.2021.44923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790662/
https://www.ncbi.nlm.nih.gov/pubmed/35076701
http://dx.doi.org/10.1001/jamanetworkopen.2021.44923

Ejemplares similares